Mathys & Squire IP Firm, The Shard, 32 London Bridge St, London SE1 9SG
4th March 2024
1 – 5pm
The afternoon before BioWales in London, MediWales will be holding a pre-event at the Shard, hosted by Mathys & Squire IP Firm.
Building on the conversations we had at our BioWales in Oxford event, in this event we will be discussing tech transfer, spin out, investment, IP and cluster development.
Please note registering for our BioWales in London event on the 5th March does not automatically register you for this event. You can register for our BioWales in London pre-event here.
Event programme:
1 – 1:30pm Registration and refreshments
1:30pm Welcome and Opening Presentations:
MediWales, Gwyn Tudor, CEO
Mathys & Squire, Craig Titmus, UK & European Patent Attorney
Sue Rees Associates, Sue Rees, Director
Welsh Government, Julie Russell, Business Development Manager, Inward Investment
2:30 – 3:30pm Panel Discussion: Spin Out, Growth and Raising Finance – Creating, financing and growing a successful life science business in Wales.
Chair: Sue Rees Associates, Sue Rees, Director
Development Bank of Wales, Mark Bowman, Venture Fund Manager
Creo Medical, Chris Hancock, CTO and Founder
Imspex Diagnostics, John McKinley, CEO
EthicsGrade, Charles Radclyffe, CEO
Llusern Scientific, Emma Hayhurst, CEO
Mathys & Squire, Martin MacLean, UK & European Patent Attorney
PeriPear Ltd, Eviatar Natan, Director
4 – 5pm Panel Discussion: Tech Transfer and Cluster Development – The vital role of research, industry, finance and healthcare and the networks that bring them together.
Development Bank of Wales, Richard Thomson, Senior Investment Executive
OMass Therapeutics, Jonathan Hopper, VP and Founder
PwC, Phil Sampson, Head of Deals
Cardiff Capital Region, Toby Williams, Cluster Development Manager
Mathys & Squire, Craig Titmus, UK & European Patent Attorney and David Hobson, UK & European Patent Attorney
Networking and close